Interim Analysis Results of a Phase 2 Trial of Low-Dose Radiation Therapy for Palliation of Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Furlan, C. [1 ]
Bulian, P. [1 ]
Spina, M. [1 ]
Michieli, M. [1 ]
Ermacora, A. [2 ]
Tirelli, U. [1 ]
Trovo, M. [1 ]
机构：
[1] CRO Aviano Natl Canc Inst, Aviano, Italy
[2] Osped Santa Maria degli Angeli, Pordenone, Italy
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
171
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell
    Lee, Ga-In
    Oh, Dongryul
    Kim, Won Seog
    Kim, Seok Jin
    Ko, Young Hyeh
    Woo, Kyung In
    Kim, Yoon-Duck
    Ahn, Yong Chan
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 575 - 581
  • [32] PALLIATION BY LOW-DOSE LOCAL RADIATION THERAPY FOR INDOLENT NON-HODGKIN LYMPHOMA
    Chan, Elisa K.
    Fung, Sharon
    Gospodarowicz, Mary
    Hodgson, David
    Wells, Woodrow
    Sun, Alexander
    Pintile, Melania
    Tsang, Richard W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : E781 - E786
  • [33] Targeting HDACs for diffuse large B-cell lymphoma therapy
    Wu, Chunyan
    Song, Qiao
    Gao, Sophie
    Wu, Shaoling
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [34] Therapy of elderly patients with diffuse large B-cell lymphoma
    Pfreundschuh, M.
    ONKOLOGIE, 2011, 34 : 88 - 88
  • [35] Targeting HDACs for diffuse large B-cell lymphoma therapy
    Chunyan Wu
    Qiao Song
    Sophie Gao
    Shaoling Wu
    Scientific Reports, 14
  • [36] Therapy for diffuse large B-cell lymphoma: getting personal
    Cheson, Bruce D.
    LANCET, 2013, 381 (9880): : 1793 - 1794
  • [37] Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial
    Xu, Peng-Peng
    Fu, Di
    Li, Jian-Yong
    Hu, Jian-Da
    Wang, Xin
    Zhou, Jian-Feng
    Yu, Hao
    Zhao, Xia
    Huang, Yao-Hui
    Jiang, Lu
    Liu, Feng
    Su, Li-Ping
    Chen, Zhuo-Wen
    Zeng, Qing-Shu
    Chen, Jie-Ping
    Fang, Mei-Yun
    Ma, Jun
    Liu, Ting
    Song, Yong-Ping
    Yu, Kang
    Li, Yan
    Qiu, Lu-Gui
    Chen, Xie-Qun
    Gu, Jian
    Yon, Jin-Song
    Hou, Ming
    Huang, Heng-Ye
    Wang, Li
    Cheng, Shu
    Shen, Yang
    Xiang, Hui
    Chen, Sai-Juan
    Zhao, Wei-Li
    LANCET HAEMATOLOGY, 2019, 6 (06): : E328 - E337
  • [38] Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma
    Ward, Jeffrey P.
    Berrien-Elliott, Melissa M.
    Gomez, Felicia
    Luo, Jingqin
    Becker-Hapak, Michelle
    Cashen, Amanda F.
    Wagner-Johnston, Nina D.
    Maddocks, Kami
    Mosior, Matthew
    Foster, Mark
    Krysiak, Kilannin
    Schmidt, Alina
    Skidmore, Zachary L.
    Desai, Sweta
    Watkins, Marcus P.
    Fischer, Anne
    Griffith, Malachi
    Griffith, Obi L.
    Fehniger, Todd A.
    Bartlett, Nancy L.
    BLOOD, 2022, 139 (13) : 1999 - 2010
  • [39] Rituximab maintenance therapy in diffuse large B-cell lymphoma
    Trajkova, S.
    Panovska-Stavridis, I.
    Stojanovik, A.
    Dukovski, D.
    Cevreska, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S22 - S23
  • [40] A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma
    Shree, Tanaya
    Khodadoust, Michael S.
    Czerwinski, Debra K.
    Frank, Matthew J.
    Hong, Wan X.
    Greenstein, Rachel
    Long, Steven R.
    Martin, Brock
    Levy, Ronald
    BLOOD, 2019, 134
12345